Formate → HCID 53887049, compound
Reaction equation
[CH:1]12[CH2:9][CH2:8][CH:5]([CH2:6][CH2:7]1)[CH2:4][N:3]([C:10]([CH2:12][N:13]1[C:19]3[CH:20]=[CH:21][CH:22]=[CH:23][C:18]=3[C:17]([CH:24]([CH3:26])[CH3:25])=[N:16][CH:15]([NH:27]C(OCC3C=CC=CC=3)=O)[C:14]1=[O:38])=[O:11])[CH2:2]2.C([O-])=O>CO.[Pd]>[NH2:27][CH:15]1[N:16]=[C:17]([CH:24]([CH3:25])[CH3:26])[C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][C:19]=2[N:13]([CH2:12][C:10]([N:3]2[CH2:2][CH:1]3[CH2:7][CH2:6][CH:5]([CH2:8][CH2:9]3)[CH2:4]2)=[O:11])[C:14]1=[O:38]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
Pd—C (5 wt %, 0.10 g) was added to a suspension of (3RS)-1-[(3-azabicyclo[3.2.2]non-3-yl)carbonylmethyl]-3-benzyloxycarbonylamino-2,3-dihydro-5-isopropyl-1H-1,4-benzodiazepin-2-one (0.718 g) in methanol (20 ml) and then anmonium formate (0.351 g) at room temperature. The mixture was stirred at the same condition for 4 hours and filtered on Celite® to remove the catalyst. The filtrate was concentrated in vacuo and the residue was taken up with ethyl acetate (100 ml) and a saturated aqueous sodium hydrogen carbonate (50 ml). The organic layer was washed with a brine (50 ml) and dried over anhydrous sodium sulfate. Filtration and evaporation gave (3RS)-3-amino-1-[(3-azabicyclo[3.2.2]non-3-yl)carbonylmethyl]-2,3-dihydro-5-isopropyl-1H-1,4-benzodiazepin-2-one (0.39 g) which was used in a following reaction step without further purification.
Workup
- customat room temperature
- filtrationfiltered on Celite®
- customto remove the catalyst
- concentrationThe filtrate was concentrated in vacuo
- washThe organic layer was washed with a brine (50 ml)
- dry with materialdried over anhydrous sodium sulfate
- filtrationFiltration and evaporation
Sources & evidence
- ORD record
- ord-acf002419e41499fae4d5dea647e27f9
- Source dataset
- uspto-grants-2001_09
- Patent number
- US06291452B1
Reaction notes
Loading…